Identification and characterization of ceftriaxone resistance and extended-spectrum β-lactamases in Malawian bacteraemic Enterobacteriaceae

Journal of Antimicrobial Chemotherapy

Volumn 57, Issue 4, 2006, Pages 661-665

  Gray, Katherine J ^a,b   Wilson, Lorna K ^a   Phiri, Amos ^a   Corkill, John E ^b   French, Neil ^a,c   Hart, C Anthony ^b  

^a MALAWI LIVERPOOL WELLCOME TRUST CLINICAL RESEARCH PROGRAMME   (Malawi)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; ESBLs; Molecular epidemiology

Indexed keywords

AMOXICILLIN; AMPICILLIN; BACTERIAL DNA; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN;

AMPLICON; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOLOGICAL MONITORING; BLOOD CULTURE; CONTROLLED STUDY; DNA SEQUENCE; DRUG SENSITIVITY; DRUG USE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENETIC ANALYSIS; GENOTYPE; HUMAN; ISOELECTRIC FOCUSING; MALAWI; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS;

ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; BLOOD; CEFTRIAXONE; CEPHALOSPORIN RESISTANCE; CHILD; CHILD, PRESCHOOL; CONJUGATION, GENETIC; CULTURE MEDIA; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGY, MOLECULAR; ESCHERICHIA COLI; HUMANS; MALAWI; MICROBIAL SENSITIVITY TESTS;

EID: 33645126266     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl037     Document Type: Article

References (23)

1. Pitout JD, Thomson KS, Hanson ND et al. β-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 1998; 42: 1350-4.
2. Essack SY, Hall LM, Pillay DG et al. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob Agents Chemother 2001; 45: 88-95.
3. Kruger T, Szabo D, Keddy KH et al. Infections with nontyphoidal Salmonella species producing TEM-63 or a novel TEM enzyme,TEM-131, in South Africa. Antimicrob Agents Chemother 2004; 48: 4263-70.
4. Ben-Hamouda T, Foulon T, Ben-Mahrez K. Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Tunisian neonatal ward. Microb Drug Resist 2004; 10: 132-8.
5. Gangoue-Pieboji J, Bedenic B, Koulla-Shiro S et al. Extended-spectrum-β-lactamase-producing Enterobacteriaceae in Yaounde, Cameroon. J Clin Microbiol 2005; 43: 3273-7.
6. CTX-M-15-carrying element. Antimicrob Agents Chemother 2005; 49: 441-3.
7. Blomberg B, Jureen R, Manji KP et al. High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended spectrum β-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 2005; 43: 745-9.
8. Gordon MA, Walsh AL, Chaponda M et al. Bacteraemia and mortality among adult medical admissions in Malawi - predominance of non-typhi salmonellae and Streptococcus pneumoniae. J Infect 2001; 42: 44-9.
9. Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005; 56: 463-9.
10. Andrews JM. BSAC standardized disc susceptibility testing method (version 4). J Antimicrob Chemother 2005; 56: 60-76.
11. Sayeed S, Saunders JR, Edwards C et al. Expression of Aeromonas caviae bla genes in Escherichia coli. J Antimicrob Chemother 1996; 38: 435-41.
12. Nuesch-Inderbinen MT, Hachler H, Kayser FH. Detection of genes coding for extended-spectrum SHV β-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 1996; 15: 398-402.
13. Gniadkowski M, Schneider I, Palucha A et al. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob Agents Chemother 1998; 42: 827-32.
14. Jacoby GA, Chow N, Waites KB. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 2003; 47: 559-62.
15. Corkill JE, Anson JJ, Hart CA. High prevalence of the plasmidmediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK. J Antimicrob Chemother 2005; 56: 1115-17.
16. Corkill JE, Hart CA, McLennan AG et al. Characterization of a β-lactamase produced by Pseudomonas paucimobilis. J Gen Microbiol 1991; 137: 1425-9.
17. Ambler RP, Coulson AF, Frere JM et al. A standard numbering scheme for the class A β-lactamases. Biochem J 1991; 276: 269-70.
18. Nuesch-Inderbinen MT, Kayser FH, Hachler H. Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: Two novel enzymes, SHV-11 and SHV-12. Antimicrob Agents Chemother 1997; 41: 943-9.
19. Corkill JE, Cuevas LE, Gurgel RQ et al. SHV-27, a novel cefotaxime-hydrolysing β-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital. J Antimicrob Chemother 2001; 47: 463-5.
20. Corkill JE, Hart CA, Shears P. Plasmid mediated ceftazidime resistance associated with a β-lactamase giving a slow nitrocefin reaction. J Antimicrob Chemother 1989; 24: 467-70.
21. Kim J, Lim YM, Jeong YS et al. Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob Agents Chemother 2005; 49: 1572-5.
22. Hanson ND, Smith ME, Pitout JD. Enzymatic characterization of TEM-63, a TEM-type extended spectrum β-lactamase expressed in three different genera of Enterobacteriaceae from South Africa. Diagn Microbiol Infect Dis 2001; 40: 199-201.
23. Graham SM, Walsh AL, Molyneux EM et al. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans R Soc Trop Med Hyg 2000; 94: 310-4.